⌘K

Home/Filings/4/0001662252-18-000105

4//SEC Filing

Logal Adam 4

Accession 0001662252-18-000105

CIK 0001534525other

View on SEC.gov Company Profile

Filed

Nov 29, 7:00 PM ET

Accepted

Nov 30, 5:23 PM ET

Size

5.4 KB

Accession

0001662252-18-000105

Insider Transaction Report

Form 4

Period: 2018-11-28

Xenetic Biosciences, Inc.XBIO

Director

Transactions

Award
Stock Options
2018-11-28+25,000→ 25,000 total
Exercise: $3.05Exp: 2028-11-28→ Common Stock (25,000 underlying)

Footnotes (1)

[F1]The Options vest in equal quarterly installments over the twelve-month period commencing on the grant date.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Xenetic Biosciences, Inc.

CIK 0001534525

Entity typeother

Related Parties

1

filerCIK 0001356197

Filing Metadata

Form type: 4
Filed: Nov 29, 7:00 PM ET
Accepted: Nov 30, 5:23 PM ET
Size: 5.4 KB

View on SEC.gov